CO4520187A1 - Tienil- y furanil-oxazolidinonas piridocondensadas - Google Patents

Tienil- y furanil-oxazolidinonas piridocondensadas

Info

Publication number
CO4520187A1
CO4520187A1 CO97001470A CO97001470A CO4520187A1 CO 4520187 A1 CO4520187 A1 CO 4520187A1 CO 97001470 A CO97001470 A CO 97001470A CO 97001470 A CO97001470 A CO 97001470A CO 4520187 A1 CO4520187 A1 CO 4520187A1
Authority
CO
Colombia
Prior art keywords
linear
mean
branched
group
carbon
Prior art date
Application number
CO97001470A
Other languages
English (en)
Inventor
Bernd Riedl
Dieter Habich
Andreas Stolle
Martin Ruppelt
Stephan Bartel
Walter Guarnieri
Rainer Endermann
Hein-Peter Kroll
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of CO4520187A1 publication Critical patent/CO4520187A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

1. COMPUESTOS DE FORMULA GENERAL (I) FIGURA 1 EN LA CUAL A REPRESENTA UN ATOMO DE OXIGENO O DE AZUFRE O EL GRUPO -SO2 Y D, E, G y L SON IGUALES O DISTINTOS Y UNO, POR LO MENOS, DE ESTOS SUSTITUYENTES REPRESENTA UN ATOMO DE NITROGENO Y LOS OTROS SIGNIFICAN EL RESTO DE FORMULA -CR2, EN DONDE R2 SIGNIFICA HIDROGENO, CIANO, NITRO, CARBOXILO, ALQUILO, ACILO O ALCOXI, LINEAL O RAMIFICADO, CON HASTA 7 ATOMOS DE CARBONO RESPECTIVAMENTE, HALOGE- NO O UN GRUPO DE FORMULA -NR3R4, -CO-NR5R6, -NR7CO -R8 o -S(O)aR9, EN DONDE R3, R4, R5, R6, R7 y R8 SON IGUALES O DISTINTOS Y SIGNIFICAN HIDROGENO, FENILO O ALQUILO LINEAL O RAMIFICADO CON HASTA 6 ATOMOS DE CARBONO, a SIGNIFICA UN NUMERO 0, 1 o 2, R9 SIGNIFICA FENILO O ALQUILO LINEAL O RAMIFICADO CON HASTA 4 ATOMOS DE CARBONO, R1 REPRESENTA AZIDO, HIDROXILO O UN GRUPO DE FOR- MULA -OR10, O-SO2R11 o -NR12R13, EN DONDE R10 SIGNIFICA ACILO LINEAL O RAMIFICADO CON HASTA 8 ATOMOS DE CARBONO O UN GRUPO PROTECTOR DE HIDRO- XILO, R11 SIGNIFICA ALQUILO LINEAL O RAMIFICADO CON HAS- TA 4 ATOMOS DE CARBONO O FENILO QUE, DADO EL CASO, ESTA SUSTITUIDO POR ALQUILO LINEAL O RAMIFICADO CON HASTA 4 ATOMOS DE CARBONO... R12 Y R13 SON IGUALES O DISTINTOS Y SIGNIFICAN CI- CLOALQUILO CON 3 A 6 ATOMOS DE CARBONO, HIDROGENO, FENILO O ALQUILO O ALCOXI, LINEAL O RAMIFICADO, CON HASTA 8 ATOMOS DE CARBONOS RESPECTIVAMENTE O UN GRUPO PROTECTOR DE AMINO, O R12 O R13, SIGNIFI- CAN UN GRUPO DE FORMULA -CO-R14, -CS-R14 P Q OR15 OR16 O -SO2-R17, EN DONDE R14 Y R14- SON IGUALES O DISTINTOS Y SIGNIFICAN CICLOALQUILO CON 3 A 6 ATO- MOS DE CARBONO TRIFLUORMETILO, ALCOXI LINEAL O RA- MIFICADO CON HASTA 8 ATOMOS DE CARBONO, FENILO, BENCILOXI O HIDROGENO, O R14 Y R14-SIGNIFICAN AL- QUILO LINEAL O RAMIFICADO CON HASTA 8 ATOMOS DE CARBONO QUE, DADO EL CASO, ESTA SUSTITUIDO POR CIA NO, HALOGENO O TRIFLUORMETILO, O SIGNIFICAN TIOAL- QUILO O ACILO, LINEAL O REMIFICADO, CON HASTA 6 ATOMOS DE CARBONO RESPECTIVAMENTE, O SIGNIFICAN UN GRUPO DE FORMULA -NR18R19, EN DONDE R18 Y R19 SON IGUALES O DISTINTOS Y SIGNIFICAN HIDROGENO, FENILO O ALQUILO LINEAL O RAMIFICADO CON HASTA 6 ATOMOS DE CARBONO, O SIGNIFICAN UN HETEROCICLO AROMATICO DE 5 ESLABONES CON HASTA 3 HETEROATOMOS DEL GRUPO S, N Y O O...
CO97001470A 1996-01-16 1997-01-15 Tienil- y furanil-oxazolidinonas piridocondensadas CO4520187A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19601264A DE19601264A1 (de) 1996-01-16 1996-01-16 Pyrido-annellierte Thienyl- und Furanyl-Oxazolidinone

Publications (1)

Publication Number Publication Date
CO4520187A1 true CO4520187A1 (es) 1997-10-15

Family

ID=7782815

Family Applications (1)

Application Number Title Priority Date Filing Date
CO97001470A CO4520187A1 (es) 1996-01-16 1997-01-15 Tienil- y furanil-oxazolidinonas piridocondensadas

Country Status (23)

Country Link
US (1) US5827857A (es)
EP (1) EP0785200A3 (es)
JP (1) JPH09194482A (es)
KR (1) KR970059180A (es)
AU (1) AU1009897A (es)
BG (1) BG101132A (es)
BR (1) BR9700702A (es)
CA (1) CA2194938A1 (es)
CO (1) CO4520187A1 (es)
CZ (1) CZ12997A3 (es)
DE (1) DE19601264A1 (es)
EE (1) EE9700031A (es)
HR (1) HRP960615A2 (es)
HU (1) HU9700136D0 (es)
IL (1) IL119995A0 (es)
NO (1) NO970175L (es)
PL (1) PL317929A1 (es)
SG (1) SG50002A1 (es)
SK (1) SK5997A3 (es)
SV (1) SV1997000003A (es)
TN (1) TNSN97008A1 (es)
TR (1) TR199601001A1 (es)
ZA (1) ZA97303B (es)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9601666D0 (en) * 1996-01-27 1996-03-27 Zeneca Ltd Chemical compounds
US6255304B1 (en) 1997-05-30 2001-07-03 Pharmacia & Upjohn Company Oxazolidinone antibacterial agents having a thiocarbonyl functionality
JP2002501530A (ja) 1997-05-30 2002-01-15 ファルマシア・アンド・アップジョン・カンパニー チオカルボニル官能基を有するオキサゾリジノン抗菌剤
AU764184B2 (en) 1998-01-23 2003-08-14 Pharmacia & Upjohn Company Oxazolidinone combinatorial libraries, compositions and methods of preparation
EP1060179A1 (en) * 1998-02-25 2000-12-20 PHARMACIA & UPJOHN COMPANY Substituted aminomethyl isoxazoline derivatives useful as antimicrobials
PL345162A1 (en) 1998-06-05 2001-12-03 Astrazeneca Ab Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
US6867203B2 (en) 1998-12-29 2005-03-15 Abbott Laboratories Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
JP2003500397A (ja) * 1999-05-19 2003-01-07 スミスクライン ビーチャム パブリック リミテッド カンパニー Mrs阻害剤としての2−nh−ピリドンおよびピリミドン
CN1367780A (zh) * 1999-07-28 2002-09-04 法玛西雅厄普约翰美国公司 噁唑烷酮类化合物、其制备方法及其应用
US6413981B1 (en) 1999-08-12 2002-07-02 Ortho-Mcneil Pharamceutical, Inc. Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
US6297242B1 (en) 1999-08-12 2001-10-02 Ortho-Mcneil Pharmaceutical, Inc. N-substituted amidine and guanidine oxazolidinone antibacterials and methods of use thereof
US6608081B2 (en) 1999-08-12 2003-08-19 Ortho-Mcneil Pharmaceutical, Inc. Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
US6518285B2 (en) 1999-12-21 2003-02-11 Ortho Mcneil Pharmaceutical, Inc. Piperidinyloxy and pyrrolidinyloxy oxazolidinone antibacterials
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
US6514529B2 (en) 2000-03-22 2003-02-04 Pharmacia & Upjohn Company Oxazolidinone tablet formulation
MY127336A (en) 2000-03-22 2006-11-30 Upjohn Co Container for linezolid iv solution
GB0009803D0 (en) * 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
DK1301207T3 (da) 2000-06-30 2005-10-10 Pharmacia & Upjohn Co Llc Sammensætninger til behandling af bakterieinfektioner indeholdende en oxazolidinonforbindelse, sulbactam og ampicillin
DE10129725A1 (de) * 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
TW200302095A (en) * 2002-01-25 2003-08-01 Upjohn Co Oxazolidinone cotherapy
AR038536A1 (es) * 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
US7141588B2 (en) * 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
IL164195A0 (en) * 2002-03-29 2005-12-18 Upjohn Co Parenteral, intravenous, and oral administration of oxazolidinones for treating diabetic foot infections
US6868358B2 (en) * 2002-07-24 2005-03-15 The Goodyear Tire & Rubber Company Method for processing information in a tire pressure monitoring system
US7094900B2 (en) * 2002-08-12 2006-08-22 Pharmacia & Upjohn Company Llc N-Aryl-2-oxazolidinones and their derivatives
AU2003280143A1 (en) * 2002-11-21 2004-06-15 Pharmacia & Upjohn Company Llc N-(4-(piperazin-1-yl)-phenyl-2-oxazolidinone-5-carboxamide derivates and related compounds as antibacterial agents
DE10300111A1 (de) * 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
MXPA05007937A (es) * 2003-02-07 2005-09-30 Warner Lambert Co Agentes antibacterianos.
MXPA05007724A (es) * 2003-02-07 2005-09-30 Warner Lambert Co Agentes antibacterianos.
US20040204463A1 (en) * 2003-04-01 2004-10-14 Harris Christina Renee N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
WO2005019214A1 (en) * 2003-08-25 2005-03-03 Warner-Lambert Company Llc Novel antimicrobial aryloxazolidinone compounds
US7304050B2 (en) * 2003-09-16 2007-12-04 Pfizer Inc. Antibacterial agents
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (en) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
US20070155738A1 (en) 2005-05-20 2007-07-05 Alantos Pharmaceuticals, Inc. Heterobicyclic metalloprotease inhibitors
DE102005045518A1 (de) 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
CA2624310C (en) 2005-10-04 2014-01-07 Bayer Healthcare Ag Polymorphic form of 5-chloro-n-({5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophenecarboxamide
DE102005047558A1 (de) * 2005-10-04 2008-02-07 Bayer Healthcare Ag Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
TW200815428A (en) * 2006-08-15 2008-04-01 Wyeth Corp Oxazolidone derivatives as PR modulators
US7649007B2 (en) * 2006-08-15 2010-01-19 Wyeth Llc Oxazolidine derivatives as PR modulators
US7652018B2 (en) * 2006-08-15 2010-01-26 Wyeth Llc Imidazolidin-2-one derivatives useful as PR modulators
WO2008021337A1 (en) 2006-08-15 2008-02-21 Wyeth Oxazinan-2-one derivatives useful as pr modulators
DE102006051625A1 (de) * 2006-11-02 2008-05-08 Bayer Materialscience Ag Kombinationstherapie substituierter Oxazolidinone
US7998992B2 (en) * 2007-03-30 2011-08-16 Institute Of Medicinal Molecular Design, Inc. Oxazolidinone derivative having inhibitory activity on 11β-hydroxysteroid dehydrogenase type 1

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH614711A5 (es) * 1975-04-08 1979-12-14 Sandoz Ag
US4705799A (en) 1983-06-07 1987-11-10 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl benzenes useful as antibacterial agents
US4965268A (en) * 1987-10-09 1990-10-23 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
US5032605A (en) * 1987-10-09 1991-07-16 Du Pont Merck Pharmaceutical Company Aminomethyl oxooxazolidinyl oxa or thia cycloalkylbenzene derivatives useful as antibacterial agents
US4801600A (en) * 1987-10-09 1989-01-31 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
US4921869A (en) * 1987-10-09 1990-05-01 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
US5254577A (en) * 1988-07-29 1993-10-19 The Du Pont Merck Pharmaceutical Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
US5164510A (en) * 1988-09-15 1992-11-17 The Upjohn Company 5'Indolinyl-5β-amidomethyloxazolidin-2-ones
DE68918792T2 (de) 1988-09-15 1995-03-30 Upjohn Co 5-Indolinyl-5-beta-amidomethyloxazolidin-2-one, 3-(substituierte kondensierte)phenyl-5-beta amidomethyloxazolidin-2-one und 3-(Nitrogen-substituierte)phenyl-5-beta-amidomethyloxazolidin-2-one.
JP2669579B2 (ja) 1991-10-23 1997-10-29 エーザイ株式会社 オキサゾリドン誘導体
DE4332384A1 (de) * 1993-09-23 1995-03-30 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten III
TW286317B (es) * 1993-12-13 1996-09-21 Hoffmann La Roche
DE4425613A1 (de) * 1994-07-20 1996-01-25 Bayer Ag 5-gliedrige Heteroaryl-oxazolidinone

Also Published As

Publication number Publication date
NO970175D0 (no) 1997-01-15
PL317929A1 (en) 1997-07-21
HU9700136D0 (en) 1997-03-28
BR9700702A (pt) 1998-09-01
SV1997000003A (es) 1997-08-19
EP0785200A3 (de) 1999-02-10
TNSN97008A1 (fr) 2005-03-15
IL119995A0 (en) 1997-04-15
US5827857A (en) 1998-10-27
AU1009897A (en) 1997-07-24
ZA97303B (en) 1997-07-17
DE19601264A1 (de) 1997-07-17
SG50002A1 (en) 1998-06-15
HRP960615A2 (en) 1998-02-28
SK5997A3 (en) 1997-09-10
CZ12997A3 (en) 1997-08-13
EE9700031A (et) 1997-08-15
EP0785200A2 (de) 1997-07-23
NO970175L (no) 1997-07-17
CA2194938A1 (en) 1997-07-17
BG101132A (en) 1998-04-30
KR970059180A (ko) 1997-08-12
MX9700421A (es) 1997-07-31
JPH09194482A (ja) 1997-07-29
TR199601001A1 (tr) 1997-08-21

Similar Documents

Publication Publication Date Title
CO4520187A1 (es) Tienil- y furanil-oxazolidinonas piridocondensadas
CO4410194A1 (es) Heteroaril-oxazolidinonas de 6 eslabones que contienen ni- trogeno.
CO4410193A1 (es) Heteroaril-oxazolidinonas de 5 eslabones
PE55097A1 (es) Isotiazolonas
AR016131A1 (es) -oxazolidinonas triciclicamente substituidas, procedimientos para su preparacion, uso de dichos compuestos y medicamentos.
ES2136209T3 (es) Nuevos nitronilfenoles estericamente impedidos utiles como captadores de radicales libres.
CO4440628A1 (es) Derivados de pirimidina condensados con un anillo heteroci- clico
CO4560411A1 (es) Nuevas oxazolidinonas sustituidas
ES2107518T3 (es) Polimeros estabilizados con heteroatomos en la cadena principal.
ES2133416T3 (es) Ligandos de subtipos de receptores de dopamina.
CO5011045A1 (es) Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos
ES2059557T3 (es) Nuevas bis-(3,5-dicarbamoil-2,4,6-triyodo-anilidas) de acidos dicarboxilicos, procedimiento para su preparacion asi como agentes de contraste de rayos x que contienen a estos.
ECSP920893A (es) Derivados de 2-imidazolin - 5 onas y 2-imidazolin -5-tionas con propiedades fungicidas
CO4650117A1 (es) Derivados de bencilsulfuro y proceso para su produccion .
ES2026669T3 (es) Procedimiento para la preparacion y el uso terapeutico de los beta-d-fenil tioxilosidos.
ES2104794T3 (es) 3-isoxazolilfenil-compuestos, su obtencion y su empleo.
ES2059416T3 (es) 1,4-dihidropiridina-enantiomeros.
BR0210170A (pt) Agente herbicida contendo benzoilpirazol e protetores
ES2188134T3 (es) Derivados de ciclohexandiol.
ATE262509T1 (de) Indolinderivate als lichtschutzmittel
ES2180932T3 (es) Derivados de camptotecina y su uso como agentes antitumorales.
ES2155660T3 (es) Derivados de bencimidazol, de benzoxazol y de benzotiazol, utilizables como inhibidores de la interleuquina 1beta.
ES2082894T3 (es) Dihidropirido(4,3-d)pirimidinas 4-sustituidas como analgesicos y agentes antiinflamatorios topicos para el tratamiento de enfermedades de la piel.
ES2068214T3 (es) Derivado de n2-(1-carboxi-3-fenilpropil)-l-lisina y procedimiento para producir lisinopril utilizando el compuesto.
ES2143675T3 (es) Bencenosulfonil-ureas-tioureas sustituidas, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento que las contiene.